CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The CRYSTAL3 project investigates the role of cysteinyl leukotrienes in various diseases, including ocular, central nervous system, cardiovascular, and cancer. By fostering collaboration among diverse researchers, it aims to unlock therapeutic potentials and develop new products and services to address these health iss…
Cysteinyl leukotrienes (CysLTs) are potent lipid mediators of inflammation.
CysLT1 and 2 receptors are widely expressed e.g. lungs, colorectum, heart, brain & eye; and CysLT1 antagonists are prescribed to treat airway inflammation.
Excitingly, CysLT signalling was recently discovered to regulate the biology of vascular, neuronal and cancer cells underpinning its untapped therapeutic potential in other diseases. CRYSTAL3 interconnects unique and diverse researchers to create a multidisciplinary t…
UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Ireland, Dublin
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Sweden, Linkoping
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Goettingen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, HOSPITALET DE LLOBREGAT
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
